Pharmaceutical Exports Climb 7.4% in May, Continuing Upward Trend

• Pharma exports rose 7.4% YoY in May 2025 to $2.47 billion
• April-May 2025 exports climbed 4.81% to $4.96 billion
• FY 2024-25 pharma exports saw a strong 9.39% annual growth

India's drug exports and pharmaceuticals posted a year-on-year increase of 7.4 percent to US$ 2.47 billion in May 2025, from US$ 2.31 billion in the corresponding month last year, based on data released by the Ministry of Commerce and Industry.

The growth in exports in May was significantly better than 2.4 percent in May 2024. The rupee value of pharma exports increased 9.69 percent to Rs. 21,090 crore from Rs. 19,227 crore in May 2024.

Imports of pharmaceutical and medicinal products also increased. Imports in May 2025 totaled US$ 786.12 million, a 3.04 percent increase from US$ 762.91 million imported in May 2024. Imports were higher by 5.26 percent at Rs. 6,696.96 crore from Rs. 6,362.13 crore.

Also Read: Ayush Exports Gets a Boost as Ayushexcil Joins Official Certifying Agencies

Pharma exports during the first two months of the current financial year (April–May 2025) were at US dollars 4.96 billion, 4.81 percent more than US dollars 4.73 billion during the corresponding period last year. Pharma exports in rupee terms during these two months rose 7.3 percent to Rs. 42,361 crore.

Cumulative two-month import arrivals were US dollars 1.53 billion, up by 6.1 percent from US dollars 1.45 billion in the corresponding period of last year. In rupee terms, it was up by 8.6 percent to Rs. 13,104 crore.

For the entire financial year 2024–25, pharmaceutical exports from India were at a 9.39 percent growth at US dollars 30.47 billion compared to FY 2023–24's US dollars 27.85 billion. This is after having a 9.67 percent growth in the preceding year.

The continued growth is indicative of strong foreign demand for Indian medicines and ongoing buoyancy in the industry.

Earlier, the DGFT opens ‘Source from India’ specifically provides an incorporated digital interface for global buyers to connect with certified Indian exporters, to strengthen India’s pharmaceutical and trade expert ecosystem.